For the year ending 2025-12-31.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Research and development | 38 | |||
| General and administrative | 5,131 | |||
| Total operating expenses | 5,169 | |||
| Loss from operations | -5,169 | |||
| Interest income | 144 | |||
| Fair value adjustment of warrants | -67 | |||
| Other expense, net | -204 | |||
| Total other income (expense), net | 7 | |||
| Net loss | -5,162 | |||
| Basic EPS | -1.41 | |||
| Diluted EPS | -1.41 | |||
| Basic Average Shares | 3,652,285 | |||
| Diluted Average Shares | 3,652,285 | |||
Pulmatrix, Inc. (PULM)
Pulmatrix, Inc. (PULM)